Tens of thousands of people will be recruited into Alzheimer’s trials after a landmark drug was rejected for use on the NHS.

Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information ...

People with type 2 diabetes who use semaglutide drugs like Ozempic and Wegovy appear to have a lower risk of Alzheimer's ...

Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after ...

People with Type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer's compared ...

Researchers have used advanced brain-imaging techniques to determine whether language skills physically alters the brain's ...

A couple from Hull have called on the government to fund new Alzheimer's drugs, even though they say it will come "too late" ...

UK's Medicines and Healthcare products Regulatory Agency (MHRA) approved Eli Lilly's treatment for early Alzheimer's, the ...

Regulator cited significant uncertainties about the drug’s benefits, as well as the high costs to treat its severe side ...

The diabetes and weight loss drug Ozempic could lower the risk of Alzheimer’s disease among people with type 2 diabetes, ...

Semaglutide (Ozempic) was tied to a reduced risk of Alzheimer's disease diagnoses in people with type 2 diabetes, ...

Semaglutide medications — such as Ozempic, the popular diabetes medication — have been linked to a reduced risk of ...